DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
DuBois SG, Chesler L, Groshen S. et al.
Phase I study of vincristine, irinotecan, and (1)(3)(1)I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trial.
Clin Cancer Res 2012;
18: 2679-2686
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.